Brilliant Violet 421TM anti-human CD197 (CCR7) [G043H7]
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0452548
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $305.25
About this award
The University of Virginia, located in Virginia, awarded contract A207_PO-0452548 to BioLegend Inc. on June 25, 2026, for a cumulative value of $305.00. The contract encompasses the delivery of Brilliant Violet 421 anti-human CD197 (CCR7) [G043H7], a monoclonal antibody reagent utilized in flow cytometry and immunological research applications. One unit of this product was ordered at a unit price of $305.25, with delivery directed to Abhinav Arneja at the University of Virginia.
As the prime contractor, BioLegend Inc. is responsible for fulfilling the supply requirement for this laboratory reagent. The contract represents a single purchase order transaction with the University of Virginia, which serves as the contracting organization. No distinct period of performance or place of performance beyond the University of Virginia's location has been specified in the available documentation. This contract award reflects a routine procurement of specialized biological research materials by an academic institution.
Line items
| Item | Total |
|---|---|
| Brilliant Violet 421TM anti-human CD197 (CCR7) [G043H7] | $305.25 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0452548?
Contract A207_PO-0452548 was awarded to BIOLEGEND INC. by University of Virginia on June 25, 2026.
How much is contract A207_PO-0452548 worth?
Its cumulative value is $305.25.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award